

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 9.90683567 |
| 2 | * oxygen transport (GO:0015671) | 9.11933581 |
| 3 | hemoglobin metabolic process (GO:0020027) | 8.58462915 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 8.55000630 |
| 5 | * gas transport (GO:0015669) | 7.86924742 |
| 6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.11923644 |
| 7 | erythrocyte maturation (GO:0043249) | 6.29951427 |
| 8 | tetrapyrrole biosynthetic process (GO:0033014) | 6.24668458 |
| 9 | defense response to fungus (GO:0050832) | 6.17148676 |
| 10 | heme biosynthetic process (GO:0006783) | 6.09996134 |
| 11 | detection of bacterium (GO:0016045) | 5.96909148 |
| 12 | erythrocyte development (GO:0048821) | 5.85328261 |
| 13 | porphyrin-containing compound metabolic process (GO:0006778) | 5.81585367 |
| 14 | killing of cells of other organism (GO:0031640) | 5.80259141 |
| 15 | disruption of cells of other organism (GO:0044364) | 5.80259141 |
| 16 | detection of other organism (GO:0098543) | 5.75789530 |
| 17 | antibacterial humoral response (GO:0019731) | 5.62943074 |
| 18 | innate immune response in mucosa (GO:0002227) | 5.62513794 |
| 19 | antimicrobial humoral response (GO:0019730) | 5.33380962 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 5.16305285 |
| 21 | heme metabolic process (GO:0042168) | 5.02156769 |
| 22 | mucosal immune response (GO:0002385) | 4.91953907 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.76682820 |
| 24 | myeloid cell development (GO:0061515) | 4.76499576 |
| 25 | organ or tissue specific immune response (GO:0002251) | 4.75586917 |
| 26 | response to fungus (GO:0009620) | 4.73989186 |
| 27 | response to peptidoglycan (GO:0032494) | 4.72027040 |
| 28 | neutrophil activation (GO:0042119) | 4.51239670 |
| 29 | leukocyte aggregation (GO:0070486) | 4.48097164 |
| 30 | response to methylmercury (GO:0051597) | 4.34470404 |
| 31 | granulocyte activation (GO:0036230) | 4.21524154 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19566306 |
| 33 | negative regulation of cell killing (GO:0031342) | 4.19566306 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.15879128 |
| 35 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.07905166 |
| 36 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.07905166 |
| 37 | regulation of response to osmotic stress (GO:0047484) | 4.07339195 |
| 38 | detection of external biotic stimulus (GO:0098581) | 4.03710000 |
| 39 | cellular extravasation (GO:0045123) | 3.92731929 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79301396 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78999910 |
| 42 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.78862098 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72836611 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72836611 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72836611 |
| 46 | modulation by symbiont of host immune response (GO:0052553) | 3.72836611 |
| 47 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72836611 |
| 48 | modulation by symbiont of host defense response (GO:0052031) | 3.72836611 |
| 49 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.71879357 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.70703020 |
| 51 | respiratory burst (GO:0045730) | 3.69344112 |
| 52 | hydrogen peroxide catabolic process (GO:0042744) | 3.66509342 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63977086 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 3.58209413 |
| 55 | defense response to Gram-positive bacterium (GO:0050830) | 3.56411547 |
| 56 | megakaryocyte development (GO:0035855) | 3.54679631 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.54248486 |
| 58 | superoxide anion generation (GO:0042554) | 3.54063921 |
| 59 | tetrapyrrole metabolic process (GO:0033013) | 3.53158817 |
| 60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.50459268 |
| 61 | negative regulation of viral entry into host cell (GO:0046597) | 3.48566031 |
| 62 | neutrophil mediated immunity (GO:0002446) | 3.47247615 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.43233047 |
| 64 | positive regulation of fibroblast migration (GO:0010763) | 3.39652739 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.36512085 |
| 66 | regulation of platelet aggregation (GO:0090330) | 3.32842931 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27340491 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.26851452 |
| 69 | granulocyte differentiation (GO:0030851) | 3.26059501 |
| 70 | cell killing (GO:0001906) | 3.24423322 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24268346 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.18470953 |
| 73 | modulation by virus of host process (GO:0019054) | 3.17249390 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15971409 |
| 75 | response to host immune response (GO:0052572) | 3.13660923 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13660923 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.11746647 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10684406 |
| 79 | negative regulation of interleukin-6 production (GO:0032715) | 3.00862199 |
| 80 | regulation of natural killer cell differentiation (GO:0032823) | 2.99734676 |
| 81 | leukocyte degranulation (GO:0043299) | 2.99732365 |
| 82 | macrophage activation involved in immune response (GO:0002281) | 2.98858489 |
| 83 | glycine transport (GO:0015816) | 2.95687982 |
| 84 | cellular response to virus (GO:0098586) | 2.92080971 |
| 85 | negative regulation of interleukin-8 production (GO:0032717) | 2.91654414 |
| 86 | regulation of viral entry into host cell (GO:0046596) | 2.91366222 |
| 87 | microglial cell activation (GO:0001774) | 2.89629578 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.89503830 |
| 89 | regulation of erythrocyte differentiation (GO:0045646) | 2.84509894 |
| 90 | erythrocyte differentiation (GO:0030218) | 2.83022033 |
| 91 | platelet formation (GO:0030220) | 2.82279126 |
| 92 | regulation of granulocyte differentiation (GO:0030852) | 2.81420801 |
| 93 | myeloid leukocyte mediated immunity (GO:0002444) | 2.81281856 |
| 94 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80140864 |
| 95 | response to host (GO:0075136) | 2.79930267 |
| 96 | response to host defenses (GO:0052200) | 2.79930267 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79930267 |
| 98 | regulation of growth of symbiont in host (GO:0044126) | 2.79487205 |
| 99 | negative regulation of growth of symbiont in host (GO:0044130) | 2.79487205 |
| 100 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.79487205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.79884243 |
| 2 | GATA1_19941826_ChIP-Seq_K562_Human | 4.50150321 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.64459681 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38068373 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.36987407 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00855935 |
| 7 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.90289938 |
| 8 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.83841903 |
| 9 | GATA2_19941826_ChIP-Seq_K562_Human | 2.80312704 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.78810377 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55704189 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55138755 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.52634854 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.47653005 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46170349 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.33558672 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30338282 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.30294489 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.29474253 |
| 20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.28954830 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21420294 |
| 22 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.21344092 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21095647 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19336798 |
| 25 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.19253682 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06871608 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.04830967 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04696712 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03617167 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99330422 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.97238169 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96837068 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96602869 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90877289 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88604840 |
| 36 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.86687489 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86514765 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81784696 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78870913 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76018115 |
| 41 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.74502041 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.72689118 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71640166 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.70149449 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69822150 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67827188 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.66313896 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.65550078 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65279596 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61986704 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61752061 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61508149 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58493860 |
| 54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.57412229 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55471347 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55167970 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54657471 |
| 58 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.51068385 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50609161 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50234057 |
| 61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.48811311 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48110241 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46797960 |
| 64 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.44730235 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43129196 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42242215 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40927382 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39989719 |
| 69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39519107 |
| 70 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.37244434 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31302925 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29671684 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26125170 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23783338 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23689708 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23293643 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23008758 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22426269 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19401568 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17422132 |
| 81 | * P68_20966046_ChIP-Seq_HELA_Human | 1.15320531 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11671272 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11636194 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11489661 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08860583 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08815054 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07970538 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05764502 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05288485 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03016209 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01747654 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01021320 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00898879 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98299609 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96526656 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91039002 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90839245 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88924140 |
| 99 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88699257 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86582389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 6.69321293 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 6.52148284 |
| 3 | MP0005083_abnormal_biliary_tract | 4.16123632 |
| 4 | MP0003303_peritoneal_inflammation | 4.11353729 |
| 5 | MP0003436_decreased_susceptibility_to | 3.21419762 |
| 6 | MP0003724_increased_susceptibility_to | 2.86058971 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.80741989 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.80741989 |
| 9 | MP0009785_altered_susceptibility_to | 2.65606985 |
| 10 | MP0005025_abnormal_response_to | 2.58865130 |
| 11 | MP0002419_abnormal_innate_immunity | 2.57395239 |
| 12 | MP0009278_abnormal_bone_marrow | 2.54723653 |
| 13 | MP0000685_abnormal_immune_system | 2.41465303 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.29567191 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.22891817 |
| 16 | MP0008260_abnormal_autophagy | 2.15627342 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.13827894 |
| 18 | MP0001790_abnormal_immune_system | 2.07905993 |
| 19 | MP0005387_immune_system_phenotype | 2.07905993 |
| 20 | MP0002398_abnormal_bone_marrow | 1.99831854 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.94500843 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.93154139 |
| 23 | MP0001819_abnormal_immune_cell | 1.90199872 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.82309578 |
| 25 | MP0002405_respiratory_system_inflammati | 1.82091375 |
| 26 | MP0002132_abnormal_respiratory_system | 1.79955904 |
| 27 | MP0001800_abnormal_humoral_immune | 1.76934930 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.74135913 |
| 29 | MP0002722_abnormal_immune_system | 1.69073778 |
| 30 | MP0002723_abnormal_immune_serum | 1.65577437 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.65384933 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.60761516 |
| 33 | MP0006082_CNS_inflammation | 1.60419941 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.60263760 |
| 35 | MP0005671_abnormal_response_to | 1.59555055 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.57679152 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.56206775 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.54071009 |
| 39 | MP0003878_abnormal_ear_physiology | 1.54071009 |
| 40 | MP0000716_abnormal_immune_system | 1.50624887 |
| 41 | MP0002429_abnormal_blood_cell | 1.50413769 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.42374953 |
| 43 | MP0003045_fibrosis | 1.40460859 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.31537372 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.30872128 |
| 46 | MP0009764_decreased_sensitivity_to | 1.30426936 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.28638714 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.28597004 |
| 49 | MP0003866_abnormal_defecation | 1.27493558 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.25262841 |
| 51 | MP0004947_skin_inflammation | 1.22710432 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.22686768 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.17402374 |
| 54 | MP0001851_eye_inflammation | 1.13956245 |
| 55 | MP0003828_pulmonary_edema | 1.11774003 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.11322233 |
| 57 | MP0005451_abnormal_body_composition | 1.06963712 |
| 58 | MP0008469_abnormal_protein_level | 1.05528434 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.03252509 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.00793792 |
| 61 | MP0000490_abnormal_crypts_of | 0.96546748 |
| 62 | MP0005310_abnormal_salivary_gland | 0.95746907 |
| 63 | MP0004381_abnormal_hair_follicle | 0.93617482 |
| 64 | MP0009931_abnormal_skin_appearance | 0.92414843 |
| 65 | MP0000858_altered_metastatic_potential | 0.92299595 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 0.90588815 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.89476147 |
| 68 | MP0004510_myositis | 0.89068069 |
| 69 | MP0009763_increased_sensitivity_to | 0.87874294 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.85780395 |
| 71 | MP0001663_abnormal_digestive_system | 0.84997083 |
| 72 | MP0003186_abnormal_redox_activity | 0.83128092 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.82172427 |
| 74 | MP0000343_altered_response_to | 0.81020826 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.80607647 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.77696214 |
| 77 | MP0004130_abnormal_muscle_cell | 0.76818431 |
| 78 | MP0002653_abnormal_ependyma_morphology | 0.75845743 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.75238512 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.71817756 |
| 81 | MP0003075_altered_response_to | 0.71770947 |
| 82 | MP0000609_abnormal_liver_physiology | 0.69581746 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.65246034 |
| 84 | MP0003795_abnormal_bone_structure | 0.62423953 |
| 85 | MP0005164_abnormal_response_to | 0.61245923 |
| 86 | MP0001873_stomach_inflammation | 0.61209924 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.60543636 |
| 88 | MP0008995_early_reproductive_senescence | 0.59718905 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.58815771 |
| 90 | MP0008874_decreased_physiological_sensi | 0.58586353 |
| 91 | MP0004883_abnormal_blood_vessel | 0.58559670 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.56682854 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.56652336 |
| 94 | MP0003879_abnormal_hair_cell | 0.54601440 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.54571173 |
| 96 | MP0000313_abnormal_cell_death | 0.54261905 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.54241668 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.52990076 |
| 99 | MP0000598_abnormal_liver_morphology | 0.50985143 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49073359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic anemia (HP:0001931) | 7.83664685 |
| 2 | Poikilocytosis (HP:0004447) | 7.26572232 |
| 3 | Microcytic anemia (HP:0001935) | 7.19372965 |
| 4 | Abnormal hemoglobin (HP:0011902) | 6.33106967 |
| 5 | Polycythemia (HP:0001901) | 4.93833943 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.80990373 |
| 7 | Reticulocytosis (HP:0001923) | 4.60899486 |
| 8 | Toxemia of pregnancy (HP:0100603) | 4.60399128 |
| 9 | Cholelithiasis (HP:0001081) | 4.52990943 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.33894522 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.11147317 |
| 12 | Abnormal gallbladder morphology (HP:0012437) | 4.07782895 |
| 13 | Paralysis (HP:0003470) | 4.02802136 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.90078661 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.77644319 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.68542016 |
| 17 | Acanthocytosis (HP:0001927) | 3.66716363 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.46789832 |
| 19 | Obstructive lung disease (HP:0006536) | 3.38198439 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38198439 |
| 21 | Myositis (HP:0100614) | 3.34474235 |
| 22 | Abnormality of iron homeostasis (HP:0011031) | 3.33743368 |
| 23 | Urticaria (HP:0001025) | 3.33109239 |
| 24 | Stomatitis (HP:0010280) | 3.28554182 |
| 25 | Diaphragmatic weakness (HP:0009113) | 3.24172855 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03165608 |
| 27 | Petechiae (HP:0000967) | 2.98767866 |
| 28 | Abnormality of the gallbladder (HP:0005264) | 2.95517294 |
| 29 | Ileus (HP:0002595) | 2.94028223 |
| 30 | Abnormality of reticulocytes (HP:0004312) | 2.91196032 |
| 31 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.83663619 |
| 32 | Osteomyelitis (HP:0002754) | 2.74878599 |
| 33 | Orchitis (HP:0100796) | 2.73960216 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.73019221 |
| 35 | Meningitis (HP:0001287) | 2.72962265 |
| 36 | Epistaxis (HP:0000421) | 2.72900782 |
| 37 | Cellulitis (HP:0100658) | 2.71783032 |
| 38 | Gingivitis (HP:0000230) | 2.68421607 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.65918861 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61475409 |
| 41 | Recurrent skin infections (HP:0001581) | 2.61148366 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.60536453 |
| 43 | Increased IgE level (HP:0003212) | 2.59336407 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.57785245 |
| 45 | Pustule (HP:0200039) | 2.56932141 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.52309122 |
| 47 | Pallor (HP:0000980) | 2.50707725 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.48269604 |
| 49 | Cholecystitis (HP:0001082) | 2.48269604 |
| 50 | Abnormal platelet volume (HP:0011876) | 2.43644191 |
| 51 | Increased serum ferritin (HP:0003281) | 2.41755731 |
| 52 | Optic neuritis (HP:0100653) | 2.40862716 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.40862716 |
| 54 | Osteomalacia (HP:0002749) | 2.36762234 |
| 55 | Encephalitis (HP:0002383) | 2.35378945 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35177974 |
| 57 | Cutaneous photosensitivity (HP:0000992) | 2.34824944 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.34470943 |
| 59 | Anorexia (HP:0002039) | 2.31995828 |
| 60 | Gingival bleeding (HP:0000225) | 2.31090121 |
| 61 | Vasculitis (HP:0002633) | 2.21977840 |
| 62 | Hypertensive crisis (HP:0100735) | 2.21218061 |
| 63 | Episodic fever (HP:0001954) | 2.15924549 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.14814428 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08960832 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08960832 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.07455297 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.01297741 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 12.9320161 |
| 70 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 12.4890674 |
| 71 | Abnormality of the pericardium (HP:0001697) | 1.97890438 |
| 72 | Chest pain (HP:0100749) | 1.97546348 |
| 73 | Hepatosplenomegaly (HP:0001433) | 1.95186980 |
| 74 | Leukocytosis (HP:0001974) | 1.92373479 |
| 75 | Gastrointestinal dysmotility (HP:0002579) | 1.91908182 |
| 76 | Purpura (HP:0000979) | 1.91046576 |
| 77 | Granulocytopenia (HP:0001913) | 1.88059482 |
| 78 | Metaphyseal cupping (HP:0003021) | 1.87317104 |
| 79 | Slow saccadic eye movements (HP:0000514) | 1.86292212 |
| 80 | Recurrent viral infections (HP:0004429) | 1.84310844 |
| 81 | Thrombophlebitis (HP:0004418) | 1.82619342 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 1.81342201 |
| 83 | Pulmonary infiltrates (HP:0002113) | 1.78355665 |
| 84 | Increased IgM level (HP:0003496) | 1.77184211 |
| 85 | Hypertriglyceridemia (HP:0002155) | 1.76533361 |
| 86 | Paresthesia (HP:0003401) | 1.75972908 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 1.73753614 |
| 88 | Increased mean platelet volume (HP:0011877) | 1.72619707 |
| 89 | Splenomegaly (HP:0001744) | 1.72505928 |
| 90 | Skin rash (HP:0000988) | 1.69960592 |
| 91 | Nasal polyposis (HP:0100582) | 1.69127720 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.68393802 |
| 93 | Difficulty running (HP:0009046) | 1.68222722 |
| 94 | Impaired platelet aggregation (HP:0003540) | 1.67751865 |
| 95 | Abnormal platelet function (HP:0011869) | 1.67751865 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 1.67432434 |
| 97 | Nausea (HP:0002018) | 1.65248916 |
| 98 | Bruising susceptibility (HP:0000978) | 1.65021054 |
| 99 | Sepsis (HP:0100806) | 1.65010338 |
| 100 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.63082392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 4.46752712 |
| 2 | TAOK1 | 3.82052823 |
| 3 | RIPK4 | 3.75919900 |
| 4 | PRPF4B | 3.67492918 |
| 5 | GRK6 | 3.50597754 |
| 6 | EIF2AK1 | 3.37890604 |
| 7 | MAP3K11 | 3.20810625 |
| 8 | TAOK2 | 2.93808350 |
| 9 | MAP3K3 | 2.91496847 |
| 10 | TNK2 | 2.78006372 |
| 11 | ERN1 | 2.66243210 |
| 12 | MAP4K1 | 2.60839794 |
| 13 | IRAK4 | 2.45933942 |
| 14 | FES | 1.94072547 |
| 15 | SYK | 1.66475722 |
| 16 | FGR | 1.64021499 |
| 17 | BLK | 1.58675010 |
| 18 | TYK2 | 1.57974502 |
| 19 | ZAP70 | 1.56408240 |
| 20 | BTK | 1.54524551 |
| 21 | CSK | 1.47931709 |
| 22 | MAP3K1 | 1.42252715 |
| 23 | HCK | 1.40495601 |
| 24 | MARK3 | 1.36951210 |
| 25 | BMX | 1.31495780 |
| 26 | PTK2B | 1.27999571 |
| 27 | TRIB3 | 1.24107296 |
| 28 | EPHB1 | 1.23152907 |
| 29 | PIM1 | 1.17970062 |
| 30 | LYN | 1.16525951 |
| 31 | IKBKE | 1.10651763 |
| 32 | SMG1 | 1.10294198 |
| 33 | JAK2 | 1.09602595 |
| 34 | CLK1 | 1.03145183 |
| 35 | MAP3K5 | 1.02939340 |
| 36 | SIK3 | 1.01891825 |
| 37 | DYRK3 | 1.01623852 |
| 38 | MAP3K6 | 1.01454851 |
| 39 | TBK1 | 0.98996115 |
| 40 | HIPK2 | 0.94410261 |
| 41 | MARK2 | 0.93085939 |
| 42 | SIK2 | 0.91960879 |
| 43 | PRKD2 | 0.90741555 |
| 44 | STK11 | 0.90691795 |
| 45 | TEC | 0.90459690 |
| 46 | KSR2 | 0.84671288 |
| 47 | STK4 | 0.83294064 |
| 48 | RPS6KC1 | 0.82817638 |
| 49 | RPS6KL1 | 0.82817638 |
| 50 | WNK1 | 0.82423988 |
| 51 | PTK6 | 0.81562290 |
| 52 | MAP2K4 | 0.80921570 |
| 53 | YES1 | 0.80518116 |
| 54 | JAK3 | 0.78300385 |
| 55 | SGK3 | 0.78237871 |
| 56 | TESK2 | 0.76814557 |
| 57 | CDK19 | 0.74367368 |
| 58 | LCK | 0.74128744 |
| 59 | RPS6KA6 | 0.69913920 |
| 60 | MAP3K10 | 0.69544743 |
| 61 | DYRK1B | 0.68058165 |
| 62 | MAP3K8 | 0.67304455 |
| 63 | TXK | 0.65821613 |
| 64 | IKBKB | 0.65671641 |
| 65 | MAPK12 | 0.62339595 |
| 66 | PDPK1 | 0.61655125 |
| 67 | PDK1 | 0.58384322 |
| 68 | ITK | 0.57469094 |
| 69 | SIK1 | 0.54435035 |
| 70 | RPS6KA5 | 0.52540316 |
| 71 | CAMK1D | 0.52092111 |
| 72 | SGK2 | 0.50558504 |
| 73 | MAP2K1 | 0.49416898 |
| 74 | KIT | 0.48961026 |
| 75 | TRPM7 | 0.48810255 |
| 76 | ICK | 0.47948090 |
| 77 | RPS6KA2 | 0.47614026 |
| 78 | FYN | 0.45962371 |
| 79 | MAP3K14 | 0.45383561 |
| 80 | MAP2K2 | 0.45321772 |
| 81 | CDK12 | 0.44091642 |
| 82 | KSR1 | 0.43621753 |
| 83 | MAP3K7 | 0.42637039 |
| 84 | PRKCQ | 0.41817191 |
| 85 | DAPK2 | 0.41645270 |
| 86 | CSF1R | 0.41340572 |
| 87 | MAP3K13 | 0.41170917 |
| 88 | MAPKAPK2 | 0.40901238 |
| 89 | GRK5 | 0.38701200 |
| 90 | CDK4 | 0.38165415 |
| 91 | PRKAA2 | 0.35752050 |
| 92 | TAOK3 | 0.35402589 |
| 93 | LRRK2 | 0.34300505 |
| 94 | SGK1 | 0.33535609 |
| 95 | RET | 0.33438285 |
| 96 | PRKCZ | 0.33382336 |
| 97 | JAK1 | 0.33138502 |
| 98 | STK38 | 0.33130841 |
| 99 | MAPK4 | 0.32883489 |
| 100 | MAPK11 | 0.32106783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 4.32832112 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.87421261 |
| 3 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.14002946 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.95475807 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61984238 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22935067 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00840941 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92516809 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.85363181 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84504612 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84374853 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76985146 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.73871943 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.73422449 |
| 15 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68267992 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61863705 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.55213573 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45171923 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.45016231 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44466284 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44196992 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.41362661 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41197135 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40585176 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34431103 |
| 26 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.33757893 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30095910 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28959223 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25878257 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.22180350 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.19202214 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18393081 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.18094996 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17402158 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16028984 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.15020532 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13855729 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12014158 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.11366803 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09212585 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08449438 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.05603818 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02368662 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02312381 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.00484161 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99379342 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96191282 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95876185 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.95470362 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93382133 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90017020 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89098944 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.85751799 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85067037 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83712576 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83560869 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81555374 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77771981 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76008221 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.75712429 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74462067 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73235009 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72216462 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.71878319 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71758123 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70739497 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70251529 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68240804 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68167117 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65354103 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64485374 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.64130596 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63980236 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63724936 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63504337 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.63304053 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61349768 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60519234 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57814922 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57443319 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56593273 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54773521 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.54266279 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53978584 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.53186853 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52882320 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52838721 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.52372285 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.51676830 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51603739 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.51122213 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.50484896 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50306902 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49819857 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49606702 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.45226608 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44929181 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44550235 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43874886 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42830878 |

